Yoo KY - Search Results

1

Highly effective peginterferon α-2a plus ribavirin combination therapy for chronic hepatitis C in hemophilia in Korea.

Yang SY, Lee HW, Lee YJ, Park SJ, Yoo KY, Kim HJ. Yang SY, et al. Among authors: yoo ky. Clin Mol Hepatol. 2015 Jun;21(2):125-30. doi: 10.3350/cmh.2015.21.2.125. Epub 2015 Jun 26. Clin Mol Hepatol. 2015. PMID: 26157749 Free PMC article. Clinical Trial.

2

Direct Acting Antiviral Agents in Korean Patients with Chronic Hepatitis C and Hemophilia Who Are Treatment-Naïve or Treatment-Experienced.

Lee HW, Yoo KY, Won JW, Kim HJ. Lee HW, et al. Among authors: yoo ky. Gut Liver. 2017 Sep 15;11(5):721-727. doi: 10.5009/gnl17209. Gut Liver. 2017. PMID: 28874040 Free PMC article.

3

Safety and Efficacy of B-domain Deleted Third Generation Recombinant Factor VIII (GreenGene F™) in Korean Patients with Hemophilia A: Data from a Post-marketing Surveillance Study.

Kim SK, Yoo KY, Lee KS, Hwang T, Choi YM, Choi EJ, Park SK. Kim SK, et al. Among authors: yoo ky. J Korean Med Sci. 2018 Jan 1;33(1):e5. doi: 10.3346/jkms.2018.33.e5. J Korean Med Sci. 2018. PMID: 29215814 Free PMC article. Clinical Trial.

4

Low Incidence of Hepatocellular Carcinoma after Antiviral Therapy in Patients with Chronic Hepatitis C and Hemophilia.

Kim IJ, Yoo SH, Kim S, Cho YY, Yoo KY, Kim HJ, Lee HW. Kim IJ, et al. Among authors: yoo sh, yoo ky. J Clin Med. 2022 Mar 7;11(5):1451. doi: 10.3390/jcm11051451. J Clin Med. 2022. PMID: 35268541 Free PMC article.

5

The first case of postpartum acquired hemophilia A in Korea.

Lee JH, Kim DH, Yoo K, Choi Y, Kim SH, Kim HJ. Lee JH, et al. J Korean Med Sci. 2011 Sep;26(9):1247-9. doi: 10.3346/jkms.2011.26.9.1247. Epub 2011 Sep 1. J Korean Med Sci. 2011. PMID: 21935285 Free PMC article.

6

Baek HJ, Park YS, Yoo KY, Cha JH, Kim YJ, Lee KS. Baek HJ, et al. Among authors: yoo ky. PLoS One. 2020 Sep 3;15(9):e0238686. doi: 10.1371/journal.pone.0238686. eCollection 2020. PLoS One. 2020. PMID: 32881977 Free PMC article.

7

Immune tolerance induction in patients with severe hemophilia A with inhibitors.

Ryu JE, Park YS, Yoo KY, Lee KD, Choi YM. Ryu JE, et al. Among authors: yoo ky. Blood Res. 2015 Dec;50(4):248-53. doi: 10.5045/br.2015.50.4.248. Epub 2015 Dec 21. Blood Res. 2015. PMID: 26770953 Free PMC article.

8

Long-term course of anti-factor VIII antibody in patients with hemophilia A at a single center.

Yoo KY, Joo SC, Choi YM. Yoo KY, et al. Blood Res. 2016 Mar;51(1):37-43. doi: 10.5045/br.2016.51.1.37. Epub 2016 Mar 25. Blood Res. 2016. PMID: 27104190 Free PMC article.

9

Ethnicity-specific impact of HLA I/II genotypes on the risk of inhibitor development: data from Korean patients with severe hemophilia A.

Kim HY, Cho JH, Kim HJ, Chung HS, Kim SH, Lee KO, Jung SY, Yoo KY, Kim HJ. Kim HY, et al. Among authors: yoo ky. Ann Hematol. 2018 Sep;97(9):1695-1700. doi: 10.1007/s00277-018-3358-x. Epub 2018 May 16. Ann Hematol. 2018. PMID: 29766236 Clinical Trial.

10

Clinical Application of Factor VIII:C to VWF:Ag Ratio for the Screening of Haemophilia A Carriers.

Yoo KY, Jung SY, Choi JY, Park HR, Park YS. Yoo KY, et al. J Clin Med. 2022 Mar 18;11(6):1686. doi: 10.3390/jcm11061686. J Clin Med. 2022. PMID: 35330010 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

616 results

Search Page

Filters